Last 2,393
Change Today -78.00 / -3.16%
Volume 58.7K
MZOR On Other Exchanges
Symbol
Exchange
OTC US
NASDAQ GM
Tel Aviv
Frankfurt
As of 9:24 AM 09/21/14 All times are local (Market data is delayed by at least 15 minutes).

mazor robotics ltd (MZOR) Snapshot

Open
$2,401
Previous Close
$2,471
Day High
$2,420
Day Low
$2,390
52 Week High
01/20/14 - $4,613
52 Week Low
08/6/14 - $2,199
Market Cap
1.0B
Average Volume 10 Days
154.4K
EPS TTM
$-0.34
Shares Outstanding
42.1M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for MAZOR ROBOTICS LTD (MZOR)

Related News

No related news articles were found.

mazor robotics ltd (MZOR) Related Businessweek News

No Related Businessweek News Found

mazor robotics ltd (MZOR) Details

Mazor Robotics Ltd., together with its subsidiary, Mazor Robotics Inc., is engaged in the development, production, marketing, and servicing of medical devices for supporting surgical procedures in the fields of orthopedics and neurosurgery in the United States, Western Europe, Eastern Europe, and Asia. The company operates in the field of image guided surgery and computer assisted surgery that enables the use of surgical instruments with precision and invasiveness. It offers Renaissance surgical guidance system that transforms spine surgery from freehand procedures to guided procedures. The company was formerly known as Mazor Surgical Technologies Ltd. and changed its name to Mazor Robotics Ltd. in 2010. Mazor Robotics Ltd. was founded in 2000 and is based in Caesarea, Israel.

113 Employees
Last Reported Date: 04/9/14
Founded in 2000

mazor robotics ltd (MZOR) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $548.3K
Co-Founder and Chief Operating Officer
Total Annual Compensation: $299.1K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $388.9K
Senior Vice President of America & Global Mar...
Total Annual Compensation: $325.9K
Vice President of Sales - United States
Total Annual Compensation: $464.5K
Compensation as of Fiscal Year 2013.

mazor robotics ltd (MZOR) Key Developments

Mazor Robotics Ltd. Receives 510(K) Clearance from the U.S. Food and Drug Administration for its Renaissance X System

Mazor Robotics Ltd. received 510(k) clearance from the U.S. Food and Drug Administration for its Renaissance X system, a research and development project, which is in a very early stage of development. The Renaissance X is one of several research and development programs underway at the company and the above mentioned 510(k) clearance reflects the company's product development strategy. Prior to any commercialization efforts, the Renaissance X will require additional technology and clinical development as well as additional regulatory clearances. There is no assurance that this project will mature to be a product at any given time.

Mazor Robotics Ltd. Receives China Food and Drug Administration Approval for its Renaissance Systems

Mazor Robotics Ltd. announced that the China Food and Drug Administration has approved the company's Renaissance system, surgical guidance system that enables surgeons to conduct spine surgeries in an accurate and secure manner. In addition to gaining the necessary regulatory approvals, the company's distribution partner in China, Cicel, has coordinated seminars and hands-on-lab experiences in the U.S. for China's spine surgeons to learn about the Renaissance system and its clinical benefits.

Mazor Robotics Ltd. Announces Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2014

Mazor Robotics Ltd. announced unaudited consolidated earnings results for the second quarter and six months ended June 30, 2014. For the quarter, the company reported revenue of $4.494 million against $6.244 million a year ago. Loss from operations was $4.104 million against $0.681 million a year ago. Loss before taxes on income was $4.067 million against $4.315 million a year ago. Net loss attributable to ordinary shareholders was $4.100 million, or $0.10 per basic and diluted share, compared to $4.377 million, or $0.15 per basic and diluted share a year ago. On a non-GAAP-basis, net loss was $3.705 million, or $0.09 per basic and diluted share, compared to $0.519 million, or $0.02 per basic and diluted share a year ago. Non-GAAP operating loss was $3.709 million against $0.426 million a year ago. Net cash used in operating activities was $3.086 million against $0.151 million a year ago. Purchase of property and equipment was $0.118 million against $0.068 million a year ago. For the six months, the company reported revenue of $9.372 million against $11.150 million a year ago. Loss from operations was $7.722 million against $1.337 million a year ago. Loss before taxes on income was $7.661 million against $14.869 million a year ago. Net loss attributable to ordinary shareholders was $7.734 million, or $0.19 per basic and diluted share, compared to $14.969 million, or $0.51 per basic and diluted share a year ago. On a non-GAAP-basis, net loss was $6.913 million, or $0.17 per basic and diluted share, compared to $0.951 million, or $0.03 per basic and diluted share a year ago. Non-GAAP operating loss was $6.901 million against $0.829 million a year ago. Cash used in operating activities was $8.426 million compared to $1.792 million a year ago. Purchase of property and equipment was $0.241 million against $0.151 million a year ago.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MZOR:IT 2,393.00 -78.00

MZOR Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Elekta AB kr72.90 SEK +0.20
Medtronic Inc $66.22 USD -0.31
MRI Interventions Inc $1.19 USD +0.04
Siemens AG €96.72 EUR -0.86
Stryker Corp $82.84 USD -1.23
View Industry Companies
 

Industry Analysis

MZOR

Industry Average

Valuation MZOR Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MAZOR ROBOTICS LTD, please visit www.mazorst.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.